Consolidated Portfolio Review Corp Merck & Co., Inc. Transaction History
Consolidated Portfolio Review Corp
- $632 Billion
- Q4 2024
A detailed history of Consolidated Portfolio Review Corp transactions in Merck & Co., Inc. stock. As of the latest transaction made, Consolidated Portfolio Review Corp holds 4,715 shares of MRK stock, worth $423,218. This represents 0.07% of its overall portfolio holdings.
Number of Shares
4,715
Previous 3,942
19.61%
Holding current value
$423,218
Previous $448 Million
4.78%
% of portfolio
0.07%
Previous 0.1%
Shares
8 transactions
Others Institutions Holding MRK
# of Institutions
3,975Shares Held
1.86BCall Options Held
16MPut Options Held
15M-
Vanguard Group Inc Valley Forge, PA251MShares$22.5 Billion0.45% of portfolio
-
Black Rock Inc. New York, NY207MShares$18.6 Billion0.59% of portfolio
-
State Street Corp Boston, MA121MShares$10.9 Billion0.49% of portfolio
-
Geode Capital Management, LLC Boston, MA61.2MShares$5.49 Billion0.48% of portfolio
-
Morgan Stanley New York, NY44.2MShares$3.97 Billion0.32% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $227B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...